215 related articles for article (PubMed ID: 29441565)
1. Metabolomics and transcriptomics profiles reveal the dysregulation of the tricarboxylic acid cycle and related mechanisms in prostate cancer.
Shao Y; Ye G; Ren S; Piao HL; Zhao X; Lu X; Wang F; Ma W; Li J; Yin P; Xia T; Xu C; Yu JJ; Sun Y; Xu G
Int J Cancer; 2018 Jul; 143(2):396-407. PubMed ID: 29441565
[TBL] [Abstract][Full Text] [Related]
2. Integration of tissue metabolomics, transcriptomics and immunohistochemistry reveals ERG- and gleason score-specific metabolomic alterations in prostate cancer.
Meller S; Meyer HA; Bethan B; Dietrich D; Maldonado SG; Lein M; Montani M; Reszka R; Schatz P; Peter E; Stephan C; Jung K; Kamlage B; Kristiansen G
Oncotarget; 2016 Jan; 7(2):1421-38. PubMed ID: 26623558
[TBL] [Abstract][Full Text] [Related]
3. Plasma metabolomic profile in prostatic intraepithelial neoplasia and prostate cancer and associations with the prostate-specific antigen and the Gleason score.
Markin PA; Brito A; Moskaleva N; Lartsova EV; Shpot YV; Lerner YV; Mikhajlov VY; Potoldykova NV; Enikeev DV; La Frano MR; Appolonova SA
Metabolomics; 2020 Jun; 16(7):74. PubMed ID: 32556743
[TBL] [Abstract][Full Text] [Related]
4. Exploring targets of TET2-mediated methylation reprogramming as potential discriminators of prostate cancer progression.
Kamdar S; Isserlin R; Van der Kwast T; Zlotta AR; Bader GD; Fleshner NE; Bapat B
Clin Epigenetics; 2019 Mar; 11(1):54. PubMed ID: 30917865
[TBL] [Abstract][Full Text] [Related]
5. Integration of Metabolomics and Transcriptomics Reveals Major Metabolic Pathways and Potential Biomarker Involved in Prostate Cancer.
Ren S; Shao Y; Zhao X; Hong CS; Wang F; Lu X; Li J; Ye G; Yan M; Zhuang Z; Xu C; Xu G; Sun Y
Mol Cell Proteomics; 2016 Jan; 15(1):154-63. PubMed ID: 26545398
[TBL] [Abstract][Full Text] [Related]
6. Development of simultaneous quantitative analysis of tricarboxylic acid cycle metabolites to identify specific metabolites in cancer cells by targeted metabolomic approach.
Yamamoto T; Sato K; Yamaguchi M; Mitamura K; Taga A
Biochem Biophys Res Commun; 2021 Dec; 584():53-59. PubMed ID: 34768082
[TBL] [Abstract][Full Text] [Related]
7. GC/TOFMS analysis of metabolites in serum and urine reveals metabolic perturbation of TCA cycle in db/db mice involved in diabetic nephropathy.
Li M; Wang X; Aa J; Qin W; Zha W; Ge Y; Liu L; Zheng T; Cao B; Shi J; Zhao C; Wang X; Yu X; Wang G; Liu Z
Am J Physiol Renal Physiol; 2013 Jun; 304(11):F1317-24. PubMed ID: 23467425
[TBL] [Abstract][Full Text] [Related]
8. Metabolomics analysis reveals distinct profiles of nonmuscle-invasive and muscle-invasive bladder cancer.
Sahu D; Lotan Y; Wittmann B; Neri B; Hansel DE
Cancer Med; 2017 Sep; 6(9):2106-2120. PubMed ID: 28766915
[TBL] [Abstract][Full Text] [Related]
9. Analysis of Metabolites from the Tricarboxylic Acid Cycle for Yeast and Bacteria Samples Using Gas Chromatography Mass Spectrometry.
Seifar RM; Ten Pierick A; van Dam PTN
Methods Mol Biol; 2018; 1730():277-282. PubMed ID: 29363081
[TBL] [Abstract][Full Text] [Related]
10. Urine metabolic fingerprinting using LC-MS and GC-MS reveals metabolite changes in prostate cancer: A pilot study.
Struck-Lewicka W; Kordalewska M; Bujak R; Yumba Mpanga A; Markuszewski M; Jacyna J; Matuszewski M; Kaliszan R; Markuszewski MJ
J Pharm Biomed Anal; 2015; 111():351-61. PubMed ID: 25684700
[TBL] [Abstract][Full Text] [Related]
11. Changes in transcription and metabolism during the early stage of replicative cellular senescence in budding yeast.
Kamei Y; Tamada Y; Nakayama Y; Fukusaki E; Mukai Y
J Biol Chem; 2014 Nov; 289(46):32081-32093. PubMed ID: 25294875
[TBL] [Abstract][Full Text] [Related]
12. Combined metabolomic and correlation networks analyses reveal fumarase insufficiency altered amino acid metabolism.
Hou E; Li X; Liu Z; Zhang F; Tian Z
Biomed Chromatogr; 2018 Apr; 32(4):. PubMed ID: 29130499
[TBL] [Abstract][Full Text] [Related]
13. Differential regulation of metabolic pathways by androgen receptor (AR) and its constitutively active splice variant, AR-V7, in prostate cancer cells.
Shafi AA; Putluri V; Arnold JM; Tsouko E; Maity S; Roberts JM; Coarfa C; Frigo DE; Putluri N; Sreekumar A; Weigel NL
Oncotarget; 2015 Oct; 6(31):31997-2012. PubMed ID: 26378018
[TBL] [Abstract][Full Text] [Related]
14. A novel non-canonical Wnt signature for prostate cancer aggressiveness.
Sandsmark E; Hansen AF; Selnæs KM; Bertilsson H; Bofin AM; Wright AJ; Viset T; Richardsen E; Drabløs F; Bathen TF; Tessem MB; Rye MB
Oncotarget; 2017 Feb; 8(6):9572-9586. PubMed ID: 28030815
[TBL] [Abstract][Full Text] [Related]
15. Integration of transcriptomics and metabolomics reveals anlotinib-induced cytotoxicity in colon cancer cells.
Jia Z; Zhang Z; Tian Q; Wu H; Xie Y; Li A; Zhang H; Yang Z; Zhang X
Gene; 2021 Jun; 786():145625. PubMed ID: 33798683
[TBL] [Abstract][Full Text] [Related]
16. Metabolomic signatures of aggressive prostate cancer.
McDunn JE; Li Z; Adam KP; Neri BP; Wolfert RL; Milburn MV; Lotan Y; Wheeler TM
Prostate; 2013 Oct; 73(14):1547-60. PubMed ID: 23824564
[TBL] [Abstract][Full Text] [Related]
17. [Identification of speckle type BTB/POZ protein mutation regulated key metabolic pathways by cell based proteomics and metabolomics].
Yan M; Liu J; Xia T; Xu G; Piao H
Se Pu; 2019 Aug; 37(8):887-896. PubMed ID: 31642260
[TBL] [Abstract][Full Text] [Related]
18. GC-MS-based metabolomics reveals mechanism of action for hydrazine induced hepatotoxicity in rats.
Bando K; Kunimatsu T; Sakai J; Kimura J; Funabashi H; Seki T; Bamba T; Fukusaki E
J Appl Toxicol; 2011 Aug; 31(6):524-35. PubMed ID: 21154879
[TBL] [Abstract][Full Text] [Related]
19. Isocitrate dehydrogenase 1 sustains a hybrid cytoplasmic-mitochondrial tricarboxylic acid cycle that can be targeted for therapeutic purposes in prostate cancer.
Gonthier K; Weidmann C; Berthiaume L; Jobin C; Lacouture A; Lafront C; Harvey M; Neveu B; Loehr J; Bergeron A; Fradet Y; Lacombe L; Riopel J; Latulippe É; Atallah C; Shum M; Lambert JP; Pouliot F; Pelletier M; Audet-Walsh É
Mol Oncol; 2023 Oct; 17(10):2109-2125. PubMed ID: 37086156
[TBL] [Abstract][Full Text] [Related]
20. An optimized analytical method for cellular targeted quantification of primary metabolites in tricarboxylic acid cycle and glycolysis using gas chromatography-tandem mass spectrometry and its application in three kinds of hepatic cell lines.
Xu J; Zhai Y; Feng L; Xie T; Yao W; Shan J; Zhang L
J Pharm Biomed Anal; 2019 Jul; 171():171-179. PubMed ID: 31005043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
